These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 6387638

  • 1. [Cigarette smoking and the etiopathogenesis of pulmonary emphysema].
    Górecka D.
    Pneumonol Pol; 1984 Jul; 52(7):353-7. PubMed ID: 6387638
    [No Abstract] [Full Text] [Related]

  • 2. Two decades of research in the pathogenesis of emphysema.
    Snider GL.
    Schweiz Med Wochenschr; 1984 Jun 23; 114(25):898-906. PubMed ID: 6379868
    [Abstract] [Full Text] [Related]

  • 3. [Possibilities of the prevention and treatment of pulmonary emphysema in the light of the "proteolytic" theory of its pathogenesis].
    Nowak D.
    Pneumonol Pol; 1985 Oct 23; 53(10):492-6. PubMed ID: 3912732
    [No Abstract] [Full Text] [Related]

  • 4. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.
    Wewers MD, Casolaro MA, Sellers SE, Swayze SC, McPhaul KM, Wittes JT, Crystal RG.
    N Engl J Med; 1987 Apr 23; 316(17):1055-62. PubMed ID: 3494198
    [Abstract] [Full Text] [Related]

  • 5. [New possibilities in the treatment of pulmonary emphysema based on the knowledge of the pathogenetic mechanisms of this disease].
    Krasucka-Kluźniak A.
    Pneumonol Pol; 1983 Oct 23; 51(10):531-6. PubMed ID: 6361700
    [No Abstract] [Full Text] [Related]

  • 6. Alpha-1-antitrypsin deficiency.
    Idell S, Cohen AB.
    Clin Chest Med; 1983 Sep 23; 4(3):359-75. PubMed ID: 6357600
    [No Abstract] [Full Text] [Related]

  • 7. [Role of certain mechanisms in the pathogenesis of emphysema and a number of other lung diseases].
    Putov NV, Pokhodzeĭ IV, Kolodkina LA.
    Ter Arkh; 1985 Sep 23; 57(3):144-8. PubMed ID: 3890255
    [No Abstract] [Full Text] [Related]

  • 8. [Congenital alpha 1-antitrypsin deficiency as an aggravating factor in alveolar injury from cigarette smoke].
    Massi G, Cotumaccio R, Auconi P.
    Minerva Med; 1982 Sep 22; 73(36):2383-5. PubMed ID: 6981079
    [No Abstract] [Full Text] [Related]

  • 9. Alpha 1-antitrypsin, emphysema and smoking.
    Carrell RW.
    N Z Med J; 1984 May 23; 97(756):327-8. PubMed ID: 6610142
    [No Abstract] [Full Text] [Related]

  • 10. The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency.
    Martorana PA, Brand T, Gardi C, van Even P, de Santi MM, Calzoni P, Marcolongo P, Lungarella G.
    Lab Invest; 1993 Feb 23; 68(2):233-41. PubMed ID: 8441253
    [Abstract] [Full Text] [Related]

  • 11. The elastase-antielastase hypothesis of the pathogenesis of emphysema.
    Stone PJ.
    Clin Chest Med; 1983 Sep 23; 4(3):405-12. PubMed ID: 6196148
    [No Abstract] [Full Text] [Related]

  • 12. [Current views on the pathogenesis and treatment of pulmonary emphysema and chronic bronchitis].
    Fal A.
    Wiad Lek; 1992 Mar 23; 45(5-6):233-9. PubMed ID: 1455869
    [Abstract] [Full Text] [Related]

  • 13. Potential adverse effects of lung macrophages and neutrophils.
    Cohen AB.
    Fed Proc; 1979 Nov 23; 38(12):2644-7. PubMed ID: 227753
    [No Abstract] [Full Text] [Related]

  • 14. [The role of free radical oxidation in the development of bronchopulmonary diseases].
    Kubyshkin AV.
    Sov Med; 1989 Nov 23; (6):26-30. PubMed ID: 2678516
    [No Abstract] [Full Text] [Related]

  • 15. Clinical trials to treat the underlying cause of emphysema.
    Cohen AB.
    Monaldi Arch Chest Dis; 1994 Apr 23; 49(2):95-7. PubMed ID: 8049708
    [No Abstract] [Full Text] [Related]

  • 16. [Elastase, elastase inhibitors and chronic obstructive lung diseases].
    Kramps JA, Dijkman JH.
    Ned Tijdschr Geneeskd; 1990 Jun 09; 134(23):1127-30. PubMed ID: 2192289
    [No Abstract] [Full Text] [Related]

  • 17. The potential role of elastase inhibitors in emphysema treatment.
    Eriksson S.
    Eur Respir J; 1991 Oct 09; 4(9):1041-3. PubMed ID: 1684550
    [No Abstract] [Full Text] [Related]

  • 18. Opportunities for the development of specific therapeutic agents to treat emphysema.
    Cohen AB.
    Am Rev Respir Dis; 1979 Oct 09; 120(4):723-7. PubMed ID: 389114
    [No Abstract] [Full Text] [Related]

  • 19. [Trends in studies on the pathogenesis of pulmonary emphysema].
    Słodkowska J.
    Pneumonol Pol; 1982 Oct 09; 50(10):541-6. PubMed ID: 6189102
    [No Abstract] [Full Text] [Related]

  • 20. Proteases and protease inhibitors in chronic obstructive lung disease.
    Erikson S.
    Acta Med Scand; 1978 Oct 09; 203(6):449-55. PubMed ID: 78661
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.